Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-11-23
1997-04-15
Tsang, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 14, 514 15, 514 17, 514 13, 530327, 530326, 530328, 530329, A61K 3800, C07K 706, C07K 708
Patent
active
056209592
ABSTRACT:
The present invention provides polypeptides of the formula XX.sup.1 TrpX.sup.2 X.sup.3 X.sup.4 X.sup.5 X.sup.6 X.sup.7 NH.sub.2, methods of treatment using the polypeptides, pharmaceutical compositions comprising such polypeptides, and processes for their preparation. The polypeptides possess antagonist properties against bombesin and bombesin-like peptides and are useful in the treatment of malignant disease. M, X, X.sup.1, X.sup.2, X.sup.3, X.sup.4, X.sup.5, X.sup.6, and X.sup.7 are as defined in the specification.
REFERENCES:
patent: 4767628 (1988-08-01), Hutchinson
patent: 4943561 (1990-07-01), Heimbrook et al.
patent: 5004602 (1991-04-01), Hutchinson
patent: 5019647 (1991-05-01), Riemen et al.
patent: 5047502 (1991-09-01), Oliff et al.
patent: 5084555 (1992-01-01), Coy et al.
patent: 5100873 (1992-03-01), de Castiglione et al.
Coy, et al, J. Biol Chem, vol. 263, No. 11, pp. 5056-5060. 1988.
Martinez, et al, J. Med. Chem. 28, pp. 1874-1879, 1985.
Mahmond, S. et al., "[Psi.sup.13,14 ] Bombesin Analogues Inhibit Growth of Small Cell Lung Cancer in Vitro and in Vivo.sup.1 ", Cancer Research, 51, 1798-1802 (1991).
Mahmoud, S. et al., "Small Cell Lung Cancer Bombesin Receptors are Antagonized by Reduced Peptide Bond Analogues", Life Sciences, 44, 367-373 (1989).
Woll, P. et al., "[D-Arg.sup.1,D-Phe.sup.5, D-Trp.sup.7,9, Leu.sup.11 ]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro", Proc. Natl. Acad. Sci., 85, 1859-1863 (1988).
Coy, D.H. et al., "Probing Peptide Backbond Function in Bombesin", J. Biological Chemistry, 263(11), 5056-5060 (1988).
Tourwe, D. et al., "synthesis and Biological Activity of Bradykinin Analogues with Reduced and Ethylenic Isosteric Peptide Bond Replacements", Peptides, 562-7 (1988).
Dung Le-Nguyen et al., "Renin Substrates. Part 2. .sup.1 Rapid Solid Phase synthesis of the Ratine Sequence Tetradecapeptide Using BOP Reagent", J. Chem. Soc. Perkin Trans. I, 1915 (1987).
Martinez, J. et al., "Synthesis and Biological Activities of Some Pseudo-Peptide Analogues of Tetragastrin: The Importance of the Peptide Backbone", J. Med. Chem., 28, 1874-1879 (1985).
Walsh, J.H. et al., "Mammalian Bombesin-Like Peptides: Neuromodulators of Gastric Function and Autocrine Regulators of Lung Cancer Growth", Peptides, 6(3), 63-68 (1985).
Mancuso, A.J. et al., "Oxidation of Long-chain and Related Alcohols to Carbonyls by Dimethyl Sulfoxide Activated by Oxalyl Chloride", J. Org. Chem., 43(12), 2480-2 (1978).
Sakakibara, S. et al., "Use of Anhydrous Hydrogen Flouride in Peptide Synthesis. I. Behavior of Various Protective Groups in Anhydrous Hydrogen Fluoride", Bulletin of the Chem. Soc. of Japan, 40(9), 2164-2167 (1967).
Merrifield, R.B., et al., "Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide", J. American Chemical Society, 83, 2149-54 (1963).
Kull Frederick C.
Leban Johann J.
Glaxo Wellcome Inc.
Hrubiec Robert T.
Marshall S. G.
Tsang Cecilia
LandOfFree
Bombesin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bombesin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bombesin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-360793